Equities

Scandion Oncology A/S

Scandion Oncology A/S

Actions
  • Price (SEK)7.38
  • Today's Change0.55 / 8.05%
  • Shares traded403.76k
  • 1 Year change-57.68%
  • Beta0.0564
Data delayed at least 15 minutes, as of Aug 11 2022 17:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • SCOL:STO price moved over +9.08% to 7.45
  • SCOL:STO price rises above 50-day moving average to 7.56 at 12:53 BST
  • SCOL:STO trading volume exceeds daily average by +16.32%

Key statistics

On Thursday, Scandion Oncology A/S (SCOL:STO) closed at 7.38, 36.67% above the 52 week low of 5.40 set on Jul 22, 2022.
52-week range
Today
5.40Jul 22 202220.00Sep 08 2021
Markit short selling activity
Low
Med
High
Open7.80
High7.80
Low6.84
Bid--
Offer--
Previous close6.83
Average volume189.33k
Shares outstanding42.85m
Free float27.82m
P/E (TTM)--
Market cap292.64m SEK
EPS (TTM)-0.7505
SEK
Data delayed at least 15 minutes, as of Aug 11 2022 17:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.